283 related articles for article (PubMed ID: 17206976)
21. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
Reinheimer TM
BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
[TBL] [Abstract][Full Text] [Related]
22. Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine.
Neri I; Monari F; Valensise H; Vasapollo B; Facchinetti F; Volpe A
Am J Perinatol; 2009 Apr; 26(4):259-63. PubMed ID: 19021095
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
[TBL] [Abstract][Full Text] [Related]
24. Short-Term Outcomes of Atosiban in the Treatment of Preterm Labour at the Sultan Qaboos University Hospital, Muscat, Oman: A tertiary care experience.
Al-Riyami N; Al-Badri H; Jaju S; Pillai S
Sultan Qaboos Univ Med J; 2021 May; 21(2):e260-e265. PubMed ID: 34221474
[TBL] [Abstract][Full Text] [Related]
25. Effect of an oxytocin receptor antagonist (atosiban) on uterine electrical activity.
Hadar E; Melamed N; Aviram A; Raban O; Saltzer L; Hiersch L; Yogev Y
Am J Obstet Gynecol; 2013 Oct; 209(4):384.e1-7. PubMed ID: 23727522
[TBL] [Abstract][Full Text] [Related]
26. The use of atosiban and ritodrine in external cephalic version.
Stergiotou I; Talbot F; Yoong W
Acta Obstet Gynecol Scand; 2007; 86(8):927-9. PubMed ID: 17653876
[TBL] [Abstract][Full Text] [Related]
27. Tocolytic therapy and clinical experience. Combination therapy.
Ingemarsson I
BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
[TBL] [Abstract][Full Text] [Related]
28. A prospective randomized trial of acute tocolysis in term labour with atosiban or ritodrine.
de Heus R; Mulder EJ; Derks JB; Kurver PH; van Wolfswinkel L; Visser GH
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):139-45. PubMed ID: 18316155
[TBL] [Abstract][Full Text] [Related]
29. Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour.
Siassakos D; O'Brien K; Draycott T
J Obstet Gynaecol; 2009 Aug; 29(6):507-11. PubMed ID: 19697198
[TBL] [Abstract][Full Text] [Related]
30. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.
Goodwin TM; Paul R; Silver H; Spellacy W; Parsons M; Chez R; Hayashi R; Valenzuela G; Creasy GW; Merriman R
Am J Obstet Gynecol; 1994 Feb; 170(2):474-8. PubMed ID: 8116700
[TBL] [Abstract][Full Text] [Related]
31. Developments in the pharmacotherapeutic management of spontaneous preterm labor.
Kam KY; Lamont RF
Expert Opin Pharmacother; 2008 May; 9(7):1153-68. PubMed ID: 18422473
[TBL] [Abstract][Full Text] [Related]
32. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
[TBL] [Abstract][Full Text] [Related]
33. Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial.
Salim R; Garmi G; Nachum Z; Zafran N; Baram S; Shalev E
Obstet Gynecol; 2012 Dec; 120(6):1323-31. PubMed ID: 23168756
[TBL] [Abstract][Full Text] [Related]
34. Exploring the role of Tractocile in everyday clinical practice.
Helmer H; Brunbauer M; Rohrmeister K
BJOG; 2003 Apr; 110 Suppl 20():113-5. PubMed ID: 12763126
[TBL] [Abstract][Full Text] [Related]
35. Oxytocin antagonists for tocolysis in preterm labour -- a systematic review.
Coomarasamy A; Knox EM; Gee H; Khan KS
Med Sci Monit; 2002 Nov; 8(11):RA268-73. PubMed ID: 12444392
[TBL] [Abstract][Full Text] [Related]
36. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
Wex J; Connolly M; Rath W
BMC Pregnancy Childbirth; 2009 Jun; 9():23. PubMed ID: 19538754
[TBL] [Abstract][Full Text] [Related]
37. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
Kim A; Shim JY
BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
[TBL] [Abstract][Full Text] [Related]
38. Randomized Trials of Retosiban Versus Placebo or Atosiban in Spontaneous Preterm Labor.
Saade GR; Shennan A; Beach KJ; Hadar E; Parilla BV; Snidow J; Powell M; Montague TH; Liu F; Komatsu Y; McKain L; Thornton S
Am J Perinatol; 2021 Aug; 38(S 01):e309-e317. PubMed ID: 32380566
[TBL] [Abstract][Full Text] [Related]
39. [Tocolysis. Atosiban, an ocytcin-receptor antagonist].
Schmitz T; Cabrol D
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):238-45. PubMed ID: 11397999
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the efficacy of atosiban in pregnant women with threatened preterm labor associated with assisted reproductive technology.
Xu YJ; Ran LM; Zhai SS; Luo XH; Zhang YY; Zhou ZY; Liu YH; Ren LD; Hong T; Liu R
Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1881-7. PubMed ID: 27212183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
